FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3195047356> ?p ?o ?g. }

• W3195047356 endingPage "1080" @default.
• W3195047356 startingPage "1080" @default.
• W3195047356 abstract "Compared with the operating room (OR), office-based intravitreal injection (IVI) is considered a more cost-effective and convenient approach, yet clinical outcomes of IVIs with anti-vascular endothelial growth factor (VEGF) agents in different settings (office-based vs OR) have not been systematically evaluated.To evaluate the safety outcomes of IVI with anti-VEGF agents in the OR vs office-based setting.PubMed, Embase, Cochrane Library, Web of Science, and ClinicalTrials.gov were searched from inception to July 2020.Eligible studies reporting on patients who received IVIs with anti-VEGF drugs with a clearly stated injection setting of the office or OR.Two reviewers independently screened studies, extracted data, and assessed risk of bias. A meta-analysis was conducted to determine the rates of endophthalmitis (EO) and culture-positive EO.Rates of EO and culture-positive EO following anti-VEGF IVIs in the OR and office-based setting.Thirty-one studies with a total of 1 275 815 injections were included. Comparative analysis suggested no difference between rates of EO after IVIs performed in the office and OR settings (odds ratio, 3.06; 95% CI, 0.07-139.75; P = .57; I2 = 80%) were identified, yet a higher rate of culture-positive EO was found in the office setting (odds ratio, 21.52; 95% CI, 2.39-193.55; P = .006; I2 = 0%). The pooled rates of EO following anti-VEGF IVIs were 0.03% (95% CI, 0.03-0.04) and 0.02% (95% CI, 0.01-0.04) in office and OR settings, respectively, and the pooled rates of culture-positive EO were 0.01% (95% CI, 0.01-0.02) and 0.01% (95% CI, 0-0.02). The pooled rates of other ocular and systemic adverse events were low.The rate of clinically suspected or culture-positive EO following anti-VEGF IVIs was low whether the procedure was performed in the office or OR setting. Bacterial spectrum could differ between the 2 settings. This meta-analysis could not determine if it is more appropriate to give treatment in the OR for safety reasons in low-income compared with higher-income regions in the world." @default.
• W3195047356 created "2021-08-30" @default.
• W3195047356 creator A5011314028 @default.
• W3195047356 creator A5011388287 @default.
• W3195047356 creator A5022724364 @default.
• W3195047356 creator A5026053703 @default.
• W3195047356 creator A5055267774 @default.
• W3195047356 creator A5062875840 @default.
• W3195047356 creator A5077362015 @default.
• W3195047356 date "2021-10-01" @default.
• W3195047356 modified "2023-10-16" @default.
• W3195047356 title "Safety of Receiving Anti–Vascular Endothelial Growth Factor Intravitreal Injection in Office-Based vs Operating Room Settings" @default.
• W3195047356 cites W1814739832 @default.
• W3195047356 cites W1966324000 @default.
• W3195047356 cites W1972706492 @default.
• W3195047356 cites W1979423827 @default.
• W3195047356 cites W1991144456 @default.
• W3195047356 cites W1998480542 @default.
• W3195047356 cites W2002196338 @default.
• W3195047356 cites W2016495793 @default.
• W3195047356 cites W2018122883 @default.
• W3195047356 cites W2026733639 @default.
• W3195047356 cites W2047424583 @default.
• W3195047356 cites W2059256502 @default.
• W3195047356 cites W2059742424 @default.
• W3195047356 cites W2068042309 @default.
• W3195047356 cites W2078916806 @default.
• W3195047356 cites W2079546021 @default.
• W3195047356 cites W2094092114 @default.
• W3195047356 cites W2102012604 @default.
• W3195047356 cites W2104106986 @default.
• W3195047356 cites W2108041016 @default.
• W3195047356 cites W2130626478 @default.
• W3195047356 cites W2130983963 @default.
• W3195047356 cites W2157929096 @default.
• W3195047356 cites W2165439370 @default.
• W3195047356 cites W2225502422 @default.
• W3195047356 cites W2290276911 @default.
• W3195047356 cites W2316516002 @default.
• W3195047356 cites W2318157824 @default.
• W3195047356 cites W2329117104 @default.
• W3195047356 cites W2408028484 @default.
• W3195047356 cites W2573055781 @default.
• W3195047356 cites W2602222005 @default.
• W3195047356 cites W2780254100 @default.
• W3195047356 cites W2791642043 @default.
• W3195047356 cites W2863641613 @default.
• W3195047356 cites W2884255321 @default.
• W3195047356 cites W2889702182 @default.
• W3195047356 cites W2897482503 @default.
• W3195047356 cites W2897564626 @default.
• W3195047356 cites W2910499130 @default.
• W3195047356 cites W2923603029 @default.
• W3195047356 cites W2926890862 @default.
• W3195047356 cites W2999644847 @default.
• W3195047356 cites W3012570924 @default.
• W3195047356 cites W3043017551 @default.
• W3195047356 cites W3092743899 @default.
• W3195047356 cites W4234895895 @default.
• W3195047356 cites W4243299626 @default.
• W3195047356 cites W4245047961 @default.
• W3195047356 cites W4253739719 @default.
• W3195047356 cites W4285698150 @default.
• W3195047356 doi "https://doi.org/10.1001/jamaophthalmol.2021.3096" @default.
• W3195047356 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8377608" @default.
• W3195047356 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34410325" @default.
• W3195047356 hasPublicationYear "2021" @default.
• W3195047356 type Work @default.
• W3195047356 sameAs 3195047356 @default.
• W3195047356 citedByCount "8" @default.
• W3195047356 countsByYear W31950473562021 @default.
• W3195047356 countsByYear W31950473562022 @default.
• W3195047356 countsByYear W31950473562023 @default.
• W3195047356 crossrefType "journal-article" @default.
• W3195047356 hasAuthorship W3195047356A5011314028 @default.
• W3195047356 hasAuthorship W3195047356A5011388287 @default.
• W3195047356 hasAuthorship W3195047356A5022724364 @default.
• W3195047356 hasAuthorship W3195047356A5026053703 @default.
• W3195047356 hasAuthorship W3195047356A5055267774 @default.
• W3195047356 hasAuthorship W3195047356A5062875840 @default.
• W3195047356 hasAuthorship W3195047356A5077362015 @default.
• W3195047356 hasBestOaLocation W31950473561 @default.
• W3195047356 hasConcept C118487528 @default.
• W3195047356 hasConcept C126322002 @default.
• W3195047356 hasConcept C156957248 @default.
• W3195047356 hasConcept C2776478404 @default.
• W3195047356 hasConcept C2777235844 @default.
• W3195047356 hasConcept C71924100 @default.
• W3195047356 hasConcept C95190672 @default.
• W3195047356 hasConceptScore W3195047356C118487528 @default.
• W3195047356 hasConceptScore W3195047356C126322002 @default.
• W3195047356 hasConceptScore W3195047356C156957248 @default.
• W3195047356 hasConceptScore W3195047356C2776478404 @default.
• W3195047356 hasConceptScore W3195047356C2777235844 @default.
• W3195047356 hasConceptScore W3195047356C71924100 @default.
• W3195047356 hasConceptScore W3195047356C95190672 @default.
• W3195047356 hasIssue "10" @default.
• W3195047356 hasLocation W31950473561 @default.

• next